Much of EMCI’s research & development is confidential due to intellectual property protection, proprietary research, regulatory requirements, and confidentiality agreements with partners. The following outlines research areas that EMCI is actively involved in for product commercialization. For more information, please contact us directly.

Brain Remapping Therapy

EMCI is currently developing a non-invasive brain-remapping device for use in patients with various neurological issues including stroke, traumatic brain injury, PSTD, Autism Spectrum Disorders, and other Somatosensory disorders. Clinical trials are currently underway for unihemisphere stroke and show great promise.

Drug Dosing for Diskenesia

Most patients suffering degenerative neurological diseases like Parkinson’s and dementia are prescribed medications to control symptoms and slow the disease. These drugs become less effective over time with regular use, and are currently dosed using subjective neurological examinations. EMCI is commercializing a device that measures orofacial elasticity over time allowing for greater accuracy in drug dosing.

Cardiac Tamponade Prevention

One of the risks of cardiac procedures is fluid collecting around the heart post-surgically, a condition which can cause serious complications and death without quick intervention. Current methods for preventing this involve passive chest tubes inserted during the procedure. These are known to clog with clotting blood very quickly, rendering them less effective or completely blocked after just 15 minutes. EMCI is developing an active clearance system, currently in clinical trials at several Midwestern surgical hospitals.

Pathologic Tissue Grossing

Not much has changed in the way surgical pathology samples are processed over the past 50 years. Skilled technicians use razor blades and a keen eye to dissect the tissue for fixation and slide preparation. However, this is often dangerous for the technician as they handle human tissue, where a cut of their own finger can cross contaminate the sample. EMCI is developing an automated system for tissue grossing, which will be tested at the University of Kansas Medical Center.